The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the ...

Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

LifeStance Health reports GLP-1 medications, known for weight loss, may also enhance mental health by improving mood, ...

Researchers in Japan developed an oral insulin pill that lowered blood sugar in diabetic mice, offering hope for a ...

Lilly’s experimental drug met endpoints for blood-sugar level reduction and weight loss at trial.

March 20 () - Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis ...

If you or someone you love has been diagnosed with type 1 diabetes (T1D), a genuine miracle is on the horizon: a type 1 ...

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included ...

A recent research revealed that discontinuing GLP-1 drugs for diabetes may increase the risk of cardiac events, stroke, and ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

As deaths from diabetes start to rival those from infectious threats like malaria, a new form of the condition linked to ...